Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,282 | -7,719 | -21,426 | -15,391 | -10,429 |
| Depreciation Amortization | 1,608 | 754 | 3,281 | 2,330 | 1,440 |
| Accounts receivable | -295 | 289 | -381 | 125 | 347 |
| Other Working Capital | -797 | -61 | 258 | -508 | -49 |
| Other Operating Activity | 301 | -285 | -1,412 | -1,240 | -984 |
| Operating Cash Flow | $-14,465 | $-7,022 | $-19,680 | $-14,683 | $-9,675 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -735 | -496 | -396 | -201 | -149 |
| Net Acquisitions | N/A | N/A | 292 | 292 | 292 |
| Other Investing Activity | -54 | -55 | -1 | -1 | -1 |
| Investing Cash Flow | $-790 | $-551 | $-105 | $91 | $143 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25,885 | 13,433 | 1,951 | 287 | 15 |
| Other Financing Activity | -748 | -320 | -37 | 0 | 0 |
| Financing Cash Flow | $25,138 | $13,113 | $1,913 | $287 | $15 |
| Exchange Rate Effect | 74 | 6 | 9 | -76 | -35 |
| Beginning Cash Position | 4,350 | 4,350 | 22,212 | 22,212 | 22,212 |
| End Cash Position | 14,306 | 9,896 | 4,350 | 7,830 | 12,660 |
| Net Cash Flow | $9,956 | $5,546 | $-17,862 | $-14,382 | $-9,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,465 | -7,022 | -19,680 | -14,683 | -9,675 |
| Capital Expenditure | -735 | -496 | -401 | -205 | -154 |
| Free Cash Flow | -15,200 | -7,518 | -20,080 | -14,889 | -9,828 |